Bill Gates-Funded COVID-19 Replicon Vaccine Trial Leaves 93% with Severe Blood Disorders!
A horrifying new study from Uganda exposes the deadly risks of a Bill Gates-funded self-amplifying mRNA (samRNA) vaccine trial.
The Phase 1 trial, conducted by Kitonsa et al, tested a COVID-19 replicon injection encoding the spike protein in 42 healthy adults, with catastrophic results: 93%— 39 participants— suffered severe (Grade 3 or higher) blood abnormalities after the second dose.
It’s absolutely horrific that Gates’ money is fueling this dangerous experiment in Uganda, endangering lives with reckless biotech!
The trial’s findings are chilling: severe abnormalities included thrombocytopenia (low platelet counts risking internal bleeding), lymphopenia (suppressed immune responses), and neutropenia (low neutrophils increasing infection risk), all classified as “severe or medically significant” by regulators, often requiring clinical intervention.
Shockingly, 85.4% of participants endured systemic adverse events like muscle pain, joint pain, vomiting, and fever. These effects worsened after the second dose, pointing to cumulative toxicity or immune priming.
These devastating outcomes occurred in healthy adults, raising alarms about the vaccine’s safety in broader populations.
This Gates-backed disaster, supported by his foundation alongside the FDA, BARDA, and Arcturus Therapeutics, is a betrayal of Uganda’s people.
The push to fast-track samRNA for H5N1 bird flu, despite these “deeply concerning” safety signals, shows a callous disregard for human lives.
Gates’ funding is turning Uganda into a testing ground for a technology that could wreak havoc.
